Three details from the financial report:
1. EyePoint’s cash and cash equivalents totaled $43.4 million at the end of the third quarter.
2. Operating expenses for the third quarter increased to $16.7 million from $5.6 million the prior year.
3. The company reported a third-quarter net loss of $19.2 million, or $0.20 per share, compared to a net loss of $7 million, or $0.15 per share, for the prior-year quarter.
More articles on supply chain:
Arkansas ASC pioneers rare, $150K dental robot — 5 details
OrthoIllinois selects HSTpathways software for ASC management
Frost & Sullivan recognizes NextGen Healthcare’s RCM solutions — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.